Director/PDMR Shareholding

RNS Number : 0958B

GlaxoSmithKline PLC

20 October 2009

 



 Notification of Transactions of Directors, Persons Discharging 

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 20 October 2009 of an increase in their notional interests in Ordinary shares at a price of £12.35 per share and Ordinary Share ADRs at a price of $39.58 per ADR following the notional re-investment of the dividend paid to shareholders on 8 October 2009.

	Ordinary shares	ADRs
Mr A P Witty	9,858.17
Mr J S Heslop	4,828.59
Dr M M Slaoui		2,551.29
Mrs C E Bruck Slaoui		70.68
Mr S M Bicknell	459.68
Mr J M Clarke	2,770.01
Mr M Dunoyer	1,162.28
Mr E J Gray	1,318.09
Mr S A Hussain	1,408.20
Mr D Learmouth	764.45
Mr W C Louv		924.38
Mr D J Phelan		1,423.54
Dr D Pulman		1,081.60
Mr D S Redfern	619.47
Mr J R Stéphenne	1,222.17
Ms C Thomas	666.56
Mr D E Troy		1,363.49

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a). 

V A Whyte

Deputy Company Secretary

20 October 2009

---

 

END

 

 

RDSXBLFLKBBFFBE